Boehringer Ingelheim and Wisconsin’s Propeller Health have announced  a first-of-its-kind commercial partnership that aims to use digital health tools and services to help people living with chronic obstructive pulmonary disease (COPD) and asthma better manage their disease.

Inhalers are a prime example of a drug delivery device that’s plagued by compliance and adherence issues due to patient difficulty mastering their use and the need for frequent, often daily usage to achieve maximum impact.

 
press release
article in FierceMedical Devices